Register
 Login
 Main Page
 MedTech News
Tech & Innovation
Living With a Device
 Education Center
Diagnostic Tests
Conditions
Procedures
Women's Health
Companies
Online Resources
Symptom Checker
Video Library
Dr. Stephen F. McCartney  MedTech  Hero™
Dr. Stephen F. McCartney:
Providing Medical Care For Our Troops.
About Heroes
 Join the Discussion in  Our Forums
 Community
MedTech1 Forums
 Advocacy Center
Become an Advocate
Contact Congress
Find a Patient Group
  Video Library
 
 Bookmark Us
 
advertisement
advertisement
Search the Body1 Network
   
October 13, 2008  
MEDTECH NEWS: Latest Headlines

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Discuss this Article
  • Experts Study Hand, Face Transplant Drugs


    July 06, 2004

    Researchers are studying antirejection drugs as a recent interest in hand transplants increases the possibility that a face transplant could be conducted soon.

    Dr. W.P. Andrew Lee, the University of Pittsburgh Medical Center's chief of plastic surgery, said it's a matter of when, not if, face transplants will be performed on humans. But since powerful anti-rejection drugs could hurt someone's chances of survival, Lee and others are studying how to wean transplant recipients from the drugs, or at least lower the doses of them.

    "As many as 88 percent of organ transplant recipients receive some type of opportunistic infection," Lee told the Pittsburgh Tribune-Review.

    Face transplants are getting attention across the world. At the University of Louisville, officials are likely to seek permission soon from its Institutional Review Board to transplant a face from a cadaver to a living recipient. The University of Louisville had done cadaver-to-cadaver face transplants, university spokeswoman Kathy Keadle said.

    And researchers in England and France are also discussing the possibility of performing the complicated surgeries, which involve transplanting skin, muscles, fat, blood vessels and nerves.

    Lee said face transplants make sense because surgeons can't adequately rebuild the face's of people who have been disfigured. Many times, tissue and other things are transplanted from elsewhere on someone's body, but the results are usually not perfect.

    Lee said researchers have transplanted limbs on rats and pigs, and the animals have successfully lived without anti-rejection drugs for as long as a year.

    Arthur Caplan, chairman of the department of medical ethics at the University of Pennsylvania Medical School, said face transplants have raise many serious ethical questions.

    "It's one thing to say your heart is rejecting and you're going to die within seconds. If your face is sloughing off your body _ can you imagine? It's a nightmare," Caplan said.

    Caplan and Lee agree that more animal studies are needed before face transplants become a reality. In particular, Caplan said there needs to be a national policy on them, and the psychological and social ramifications need to be thought through.

    ___

    Information from: Tribune-Review, http://www.triblive.com


    Last updated: 06-Jul-04

       
    Interact on Medtech1
    DISCUSS THIS ARTICLE
    Ask a question or share your opinions on this topic with others in the Body1 community.
     
    Latest Headlines Archives
    Going out Green – Boomers Reinvent the Funeral Industry

    The Dutch Debate Euthanasia for Infants

    Man Undergoes Web-Arranged Transplant

    States Launch Prescription Drug Program

    More Medical Devices Needed for Babies

    Next 5 Features ...

    More Headlines ...

     
    Home About Us Press Jobs Advertise With Us Contact Us
    advertisement
    ©1999- 2008 Body1, Inc. All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.
    See our Terms of Service, our Privacy Policy, our Advertising Policy and our Editorial Policy.